Castleman Disease

Fed Pract. 2015 Aug;32(Suppl 7):41S-46S.

Abstract

An understanding of the disease pathogenesis has led to the discovery of therapuetic agents that target human herpesvirus-8 replication, CD20, and IL-6 and IL-6R antibodies.